HCV inhibitors

Details HCV inhibitors HCV inhibitors

2006-06-28

2009-10-27

Russel, Jeffrey E (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S019300, C514S422000, C530S331000, C548S517000, C548S518000, C548S519000, C548S525000, C548S526000, C548S527000

Reexamination Certificate

active

07608592

ABSTRACT:
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

REFERENCES:
patent: 6268207 (2001-07-01), Bailey
patent: 6404397 (2002-06-01), Grinberg et al.
patent: 6492383 (2002-12-01), Munchhof et al.
patent: 6608027 (2003-08-01), Tsantrizos et al.
patent: 6774212 (2004-08-01), Han
patent: 6846806 (2005-01-01), Priestley
patent: 6939854 (2005-09-01), Priestly
patent: 7399749 (2008-07-01), Arasappan et al.
patent: 2003/0216325 (2003-11-01), Saksena et al.
patent: 2005/0137139 (2005-06-01), Perni et al.
patent: 2005/0267043 (2005-12-01), Bogen et al.
patent: 2006/0142204 (2006-06-01), Halfon et al.
patent: 1 136 498 (2001-09-01), None
patent: 1 437 362 (2004-07-01), None
patent: WO 99/24440 (1999-05-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 02/18369 (2002-03-01), None
patent: WO 02/18369 (2002-03-01), None
patent: WO 2004/093798 (2004-11-01), None
patent: WO 2005/028501 (2005-03-01), None
patent: WO 2005/035525 (2005-04-01), None
patent: WO 2005/035525 (2005-04-01), None
patent: WO 2005/070955 (2005-09-01), None
patent: WO 2006/043145 (2006-04-01), None
patent: WO 2007/016476 (2007-02-01), None
Malancona et al. SAR and pharmacokinetic studies on phenethylamide inhibitors . . . Bioorganic & Medicinal Chemistry Letters. 2004, vol. 14, pp. 4575-4579.
Ronn et al. Exploration of acyl sulfonamides as carboxylic acid replacements . . . Bioorganic & Medicinal Chemistry. 2006, vol. 14, pp. 544-559.
U.S. Appl. No. 11/866,836, filed Oct. 3, 2007, John Link, et al.
U.S. Appl. No. 11/968,475, filed Jan. 2, 2008, Green, et al.
Supplementary European Search Report mailed on Jun. 12, 2009, for EP Application No. 06774467.2, 6 pages.

Affiliated with

Also associated with

Rating

HCV inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HCV inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HCV inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4080517